Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Efpeglenatide Efpeglenatide is a novel, long-acting GLP-1 receptor agonist developed by Hanmi Pharmaceuticals (South Korea) utilizing the proprietary LAPSCOVERY (Long-Acting Protein/Peptide Discovery) technology platform
Maintenance Dosing & Continued Weight Management Objectives After completing the initial 8 weeks of weight management treatments, you and your provider will review your progress and long-term weight management goals
Ozempic and Mounjaro work through different mechanisms, which means maintenance strategies may differ
While everyone is different, many patients notice a decrease in appetite within the first week, with significant weight changes occurring over the first 3 to 6 months of a structured program
US$ 29.08
US$ 26.38
US$ 25.93
US$ 25.77
US$ 23.80
US$ 20.20
